SG174998A1 - C6orf167 peptides and vaccines containing the same - Google Patents

C6orf167 peptides and vaccines containing the same Download PDF

Info

Publication number
SG174998A1
SG174998A1 SG2011071370A SG2011071370A SG174998A1 SG 174998 A1 SG174998 A1 SG 174998A1 SG 2011071370 A SG2011071370 A SG 2011071370A SG 2011071370 A SG2011071370 A SG 2011071370A SG 174998 A1 SG174998 A1 SG 174998A1
Authority
SG
Singapore
Prior art keywords
c6orf167
peptides
same
vaccines containing
vaccines
Prior art date
Application number
SG2011071370A
Other languages
English (en)
Inventor
Yusuke Nakamura
Yataro Daigo
Takuya Tsunoda
Ryuji Ohsawa
Sachiko Yoshimura
Tomohisa Watanabe
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of SG174998A1 publication Critical patent/SG174998A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
SG2011071370A 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same SG174998A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21170009P 2009-04-01 2009-04-01
PCT/JP2010/002352 WO2010113495A1 (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
SG174998A1 true SG174998A1 (en) 2011-11-28

Family

ID=42827803

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011071370A SG174998A1 (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same
SG2014011423A SG2014011423A (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2014011423A SG2014011423A (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same

Country Status (14)

Country Link
US (1) US20120128705A1 (enExample)
EP (1) EP2414383A4 (enExample)
JP (1) JP5728759B2 (enExample)
KR (1) KR20120034605A (enExample)
CN (2) CN104774260A (enExample)
AU (1) AU2010231381A1 (enExample)
BR (1) BRPI1013384A2 (enExample)
CA (1) CA2757210A1 (enExample)
IL (1) IL215268A0 (enExample)
MX (1) MX2011010191A (enExample)
RU (1) RU2011144088A (enExample)
SG (2) SG174998A1 (enExample)
TW (1) TW201100090A (enExample)
WO (1) WO2010113495A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1907582B1 (en) 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
US8933014B2 (en) 2010-03-11 2015-01-13 Oncotherapy Science, Inc. HJURP peptides and vaccines including the same
WO2012023259A1 (en) * 2010-08-19 2012-02-23 Oncotherapy Science, Inc. C6orf167 as a target gene for cancer therapy and diagnosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521865A (ja) * 1997-10-24 2003-07-22 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 148個のヒト分泌タンパク質
CN1351069A (zh) * 2000-10-26 2002-05-29 上海博德基因开发有限公司 一种新的多肽——鼠的同ampa受体相互作用的蛋白grip12.54和编码这种多肽的多核苷酸
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
EP2267023B1 (en) * 2002-09-12 2015-02-11 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Cxadrl1またはgcud1タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
DK2325306T3 (en) * 2005-02-25 2014-03-03 Oncotherapy Science Inc Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP1907582B1 (en) * 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
JP5409658B2 (ja) * 2008-03-13 2014-02-05 セレラ コーポレーション 静脈血栓症に関連した遺伝子多型、その検出方法および使用

Also Published As

Publication number Publication date
BRPI1013384A2 (pt) 2016-03-29
JP5728759B2 (ja) 2015-06-03
CN102448980A (zh) 2012-05-09
EP2414383A4 (en) 2013-07-31
CA2757210A1 (en) 2010-10-07
KR20120034605A (ko) 2012-04-12
JP2012522488A (ja) 2012-09-27
RU2011144088A (ru) 2013-05-10
TW201100090A (en) 2011-01-01
EP2414383A1 (en) 2012-02-08
AU2010231381A1 (en) 2011-11-03
MX2011010191A (es) 2011-11-29
SG2014011423A (en) 2014-05-29
CN102448980B (zh) 2015-04-15
IL215268A0 (en) 2011-11-30
US20120128705A1 (en) 2012-05-24
CN104774260A (zh) 2015-07-15
WO2010113495A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
IL214435A0 (en) Foxm1 peptides and vaccines containing the same
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
IL219976A0 (en) Imp-3 oligopeptides and vaccines including the same
IL229926A0 (en) 3neil peptides and vaccines containing them
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
ZA201207416B (en) Cdca5 peptides and vaccines including the same
GB0810710D0 (en) Vaccine
IL210861A0 (en) Melk epitope peptides and vaccines containing the same
IL228995A0 (en) b5sema peptides and components containing them
PL2464656T3 (pl) Nowy peptyd i jego zastosowanie
ZA201303886B (en) Tomm34 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL216211A0 (en) Cdc45l peptides and vaccines including the same
EP2430039A4 (en) TTK-PEPTIDES AND VACCINES CONTAINING THEM
IL221474A0 (en) Hjurp peptides and vaccines including the same
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL219927A0 (en) Mybl2 peptides and vaccines containing the same
ZA201207342B (en) Ect2 peptides and vaccines including the same
IL225553A0 (en) 54orf18c peptides and vaccines containing them
IL225552A0 (en) wdhd1 peptides and vaccines containing them
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
HK1166088A (zh) C6orf167肽及包含它的疫苗
HK1166096A (en) Vangl1 peptides and vaccines including the same